Does this listing belong to you or your company?
Create an account now and claim this listing.
SQUARE Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh and it has been continuously in the 1st position among all national and multinational companies since 1985. It was established in 1958 and converted into a public limited company in 1991. The sales turnover of SPL was more than Taka 11.46 Billion (US$ 163.71 million) with about 16.43% market share (April 2009– March 2010) having a growth rate of about 16.72%.
Looking beyond the horizon
SQUARE Pharmaceuticals Limited has extended its range of services towards the highway of global market. It pioneered exports of medicines from Bangladesh in 1987 and has been exporting antibiotics and other pharmaceutical products. This extension in business and services has manifested the credibility of Square Pharmaceuticals Limited.
Chronology Since Inception
1958 : Debut of SQUARE Pharma as a Partnership Firm.
1964 : Converted into a Private Limited Company.
1974 : Technical Collaboration with Janssen Pharmaceuticals, Belgium, a subsidiary of Johnson and Johnson International, USA.
1982 : Licensing Agreement signed with F. Hoffman-La Roche & Co Ltd., Switzerland.
1985 : Achieved market-leadership in the pharmaceutical market of Bangladesh among all national and multinational companies.
1987 : Pioneer in pharmaceutical export from Bangladesh.
1991 : Converted into a Public Limited Company
1994 : Initial Public Offering of shares of SQUARE Pharmaceuticals Ltd.
1995 : Chemical Division of SQUARE Pharmaceuticals Ltd. starts production of Active Pharmaceutical Ingredients (API).
1997 : Won the National Export trophy for exporting pharmaceuticals.
1998 : Agro-chemicals & Veterinary Products division of SQUARE Pharmaceuticals starts its operation.
2001 : US FDA/UK MCA standard new pharmaceutical factory goes into operation built under the supervision of Bovis Lend Lease, UK.
2004 : SQUARE enlisted as UNICEF’s global supplier.
2005 : New State-of-the-Art SQUARE Cephalosporins Ltd. goes into operation; built under the supervision of TELSTAR S.A. of Spain as per US FDA/ UK MHRA requirements.
2007 : SQUARE Pharmaceuticals Ltd., Dhaka Unit gets the UK MHRA approval.
2009 : Starts manufacturing of insulin maintaining quality standards of US FDA & UK MHRA. Dedicated hormone & steroid products manufacturing facility complying with the current Good Manufacturing Practice (cGMP) of WHO, US FDA & UK MHRA starts operation.
2012 : SQUARE Pharmaceuticals Ltd., Dhaka Unit and SQUARE Cephalosporins Ltd. get the Therapeutic Goods Administration(TGA) of Australia approval.